Press Releases
Patient Advocates Warn of Dangers of Black Market HIV Medicines
In May 2014, the Community Access National Network (CANN) and the Partnership for Safe Medicines (PSM), released a new resource for the HIV/AIDS community and their doctors. The flyers, available online and in print form, highlighted the incidence of black market HIV/AIDS medication since 2006 and offered tips for patients and physicians to ensure they are purchasing legitimate drugs from reputable sources.
[...]Leading Patient Safety Groups Collaborate for Women’s Health Week
New infographic focuses on dangers to women’s health from counterfeit and black market medicine Washington, D.C. (May 14, 2014) – This week is women’s health week, and nationally-known patient advocates Men’s Health Network and public health advocates the Partnership for Safe Medicines (PSM) are sounding the alarm about the growing danger of counterfeit and black…
[...]More Education, Enforcement Needed to Protect Patients from Counterfeit Prescription Drugs
Washington, D.C. (February 27, 2014) – Marv Shepherd, President of the Partnership for Safe Medicines (PSM), released the following statement on today’s hearing on counterfeit medicines held by the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations. The hearing, titled “Counterfeit Drugs: Fighting Illegal Supply Chains” brought to light some disturbing trends that must…
[...]Senate Passes HR 3240, “Drug Quality and Security Act”
PSM applauds the members of the Senate for passing HR 3204, "Drug Quality and Security Act." The securing of the supply chain through establishing track-and-trace requirements for medicine manufacturers, wholesalers and repackagers will provide Americans with greater security over our prescription drugs. When the supply chain is breached by someone mistakenly purchasing a substandard drug…
[...]PSM’s Scott LaGanga to Japan Medical Association: Counterfeit Medicines a Global Health Menace
PSM Executive Director Urges Greater International Cooperation in Major Address to the Japan Medical Association TOKYO, JAPAN (September 19, 2013) – Partnership for Safe Medicines Executive Director Scott LaGanga stressed the urgent need for greater global education and collaboration to fight the growing health threat posed by counterfeit and substandard medicines in an address to…
[...]INTERPOL-Led Sting Operation Shuts Down Over 9,600 Illegal Internet Pharmacies, Seizes $41 Million in Fake, Dangerous or Unapproved Drugs
PSM’s Member PSI Aids Investigators in Largest Global Operation of its Kind Washington, D.C. (June 27, 2013) – The Partnership for Safe Medicines (PSM) applauds INTERPOL and the nearly 100 countries who took part in Operation Pangea VI, the largest global sting operation to date targeting the online sale of illegal prescription medicines. One of PSM’s…
[...]PSM Lauds House of Representatives for Approval of HR 1919
PSM applauds the members of the House of Representatives for passing HR 1919, “Safeguarding America’s Pharmaceuticals Act of 2013.”
Today, our system of prescription drug distribution heavily relies on trusting the entity you’re dealing with and their judgment. If a mistake is made, or anyone farther back in the supply chain makes a mistake in purchasing a substandard drug product, there is no ability for a good actor down the line to know this. Criminals have taken advantage of this fact, and such incidents are growing in number every year. Life-saving medications that treat osteoporosis, cancer, heart disease, and many other serious medical conditions have been faked just in the last few years, as the rules of the road have failed to keep up with the innovative nature of the criminals that prey on American patients.
PSM Supports HR 1919, ‘Safeguarding America’s Pharmaceuticals Act’
Dear Speaker Boehner and Chairman Upton:
On behalf of the Partnership for Safe Medicines (PSM), we write today in strong support of H.R.
1919, the “Safeguarding America’s Pharmaceuticals Act”.
PSM is a not for profit, consumer focused organization that seeks to
keep Americans safe from counterfeit drugs through patient and healthcare
provider education and awareness. In
the US we work with a coalition of over 70 healthcare professional and patient
groups to improve patients’ and their
healthcare providers’ knowledge about where they obtain their medication, how
they can save money safely, and how to safely identify licensed pharmaceutical
distributors.
PSM strongly supports the creation of a national uniform track and trace
or pedigree system that would allow all participants in the supply chain to
verify a product’s history of sale.
PSM Applauds INTERPOL, Industry Partnership to Combat Counterfeit Medicines
March
12, 2013 (Washington, D.C.) – The Partnership for Safe Medicines
(PSM), the leading advocacy organization dedicated to fighting the spread of
counterfeit drugs, applauds today’s
announcement of a bold new initiative between INTERPOL
and the pharmaceutical industry to combat the global health threat of
counterfeit and fake medicines.
This new initiative broadens the scope of the
successful Medical Product Counterfeiting and Pharmaceutical Crime Unit through
the creation of a Pharmaceutical Crime Program to assist and enhance worldwide
law enforcement efforts. Thomas Kubic, PSM Board Member and CEO of the
Pharmaceutical Security Institute, released the following statement hailing the
new agreement:
Partnership for Safe Medicines Announces Groundbreaking China Initiative
Launch of PSM China Reinforces Global
Fight Against Counterfeit Drugs
Beijing and Washington, D.C. (November
28, 2012) – The
Partnership for Safe Medicines (PSM), the leading advocacy organization dedicated
to fighting the global threat posed by counterfeit drugs, today announced its
latest international collaboration with the launch of PSM China. Today’s launch
event in Beijing was attended by stakeholders from the government, advocacy community and industry, and underscores the important
role that public-private partnerships play in educating consumers and helping
to keep them safe from dangerous and deadly counterfeit medicines.